Reckitt reported estimate beating Q2/H1 22 numbers, with sales up 11.9%/8.6%, respectively, on a LFL basis, as strong momentum in Health and Nutrition was partially offset by a normalisation in Hygiene.
The H1 adjusted operating margin expanded by 290bps, which is noteworthy within the context of an inflationary environment.
Following the strong H1, Reckitt upgraded its FY22 guidance. We expect a mid-to-high single digit upgrade to our estimates.

28 Jul 2022
Solid Q2 22, Lysol normalization along expected lines

Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Solid Q2 22, Lysol normalization along expected lines
Reckitt Benckiser Group plc (RKT:LON) | 5,754 805.6 0.2% | Mkt Cap: 41,291m
- Published:
28 Jul 2022 -
Author:
Virendra Chauhan -
Pages:
4 -
Reckitt reported estimate beating Q2/H1 22 numbers, with sales up 11.9%/8.6%, respectively, on a LFL basis, as strong momentum in Health and Nutrition was partially offset by a normalisation in Hygiene.
The H1 adjusted operating margin expanded by 290bps, which is noteworthy within the context of an inflationary environment.
Following the strong H1, Reckitt upgraded its FY22 guidance. We expect a mid-to-high single digit upgrade to our estimates.